ARQT
Price
$13.75
Change
-$0.27 (-1.93%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
1.67B
43 days until earnings call
Interact to see
Advertisement

ARQT

Header iconARQT Comparison
Open Charts ARQTBanner chart's image
Arcutis Biotherapeutics
Price$13.75
Change-$0.27 (-1.93%)
Volume$64.14K
Capitalization1.67B
ARQT Comparison Chart in %
Loading...
ARQT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
Interact to see
Advertisement
COMPARISON
Comparison
Jul 02, 2025
Stock price -- (ARQT: $14.02)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARQT’s FA Score shows that 0 FA rating(s) are green while.

  • ARQT’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARQT’s TA Score shows that 5 TA indicator(s) are bullish.

  • ARQT’s TA Score: 5 bullish, 2 bearish.

Price Growth

ARQT (@Biotechnology) experienced а -2.64% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.51%. For the same industry, the average monthly price growth was +32.88%, and the average quarterly price growth was +3.93%.

Reported Earning Dates

ARQT is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (-0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARQT
Capitalization1.67B
EBITDA-101.07M
Gain YTD0.646
P/E RatioN/A
Revenue213M
Total Cash198M
Total Debt111M
TECHNICAL ANALYSIS
Technical Analysis
ARQT
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARQT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APSLX15.680.01
+0.06%
NYLI Fiera SMID Growth Class C
MFLDX24.76N/A
N/A
Cromwell Long Short Institutional
SMEIX18.47N/A
N/A
Invesco Small Cap Equity R5
OIRDX27.43N/A
N/A
Invesco Rising Dividends R6
OIEJX25.08N/A
N/A
JPMorgan Equity Income R6

ARQT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARQT has been loosely correlated with NRIX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ARQT jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARQT
1D Price
Change %
ARQT100%
+2.04%
NRIX - ARQT
47%
Loosely correlated
-2.15%
BEAM - ARQT
44%
Loosely correlated
+1.25%
KRYS - ARQT
44%
Loosely correlated
-1.02%
IDYA - ARQT
43%
Loosely correlated
-1.64%
ROIV - ARQT
43%
Loosely correlated
-1.05%
More